NEW YORK – Ukraine’s recent registration of oral morphine, a strong pain medication used most frequently to treat severe cancer pain, is a major step toward improving end-of-life care, Human Rights Watch said today.
The registration, on February 1, 2013, will allow Interchem, a Ukrainian pharmaceutical company in Odessa, to begin production of 5mg and 10mg morphine tablets. The medications are expected to enter the market by March 2013.
